CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Pharmaceutical Technology
Original article

Big tech- and pharma-backed Iambic Therapeutics aims for $135m IPO

IPO/OfferingPositive
AI Analysis

Summary

Iambic Therapeutics, a tech- and pharma-backed oncology specialist, is planning a US IPO targeting $135 million in proceeds as part of a strong year for biotech IPOs.

Importance:7/10
Sentiment:
0.60
IPOoncologybiotechcapital_markets
Related Companies

Read the original article

Published by Pharmaceutical Technology on October 9, 2026 3:02 PM

Read Original